These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16986450)

  • 21. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulant ADHD medication and risk for substance abuse.
    Chang Z; Lichtenstein P; Halldner L; D'Onofrio B; Serlachius E; Fazel S; Långström N; Larsson H
    J Child Psychol Psychiatry; 2014 Aug; 55(8):878-85. PubMed ID: 25158998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription Stimulants: From Cognitive Enhancement to Misuse.
    Wilens TE; Kaminski TA
    Pediatr Clin North Am; 2019 Dec; 66(6):1109-1120. PubMed ID: 31679601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the medicating ADHD increase or decrease the risk for later substance abuse?
    Wilens TE
    Braz J Psychiatry; 2003 Sep; 25(3):127-8. PubMed ID: 12975683
    [No Abstract]   [Full Text] [Related]  

  • 28. ADHD: monitoring for and managing stimulant adverse effects.
    Mercer M; Farver D
    S D Med; 2013 Dec; 66(12):511, 513. PubMed ID: 24527549
    [No Abstract]   [Full Text] [Related]  

  • 29. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL
    J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 32. When the child with ADHD grows up.
    Sim MG; Hulse G; Khong E
    Aust Fam Physician; 2004 Aug; 33(8):615-8. PubMed ID: 15373378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The misuse and diversion of prescribed ADHD medications by college students.
    Rabiner DL; Anastopoulos AD; Costello EJ; Hoyle RH; McCabe SE; Swartzwelder HS
    J Atten Disord; 2009 Sep; 13(2):144-53. PubMed ID: 19448150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.
    Kantak KM; Dwoskin LP
    Pharmacol Biochem Behav; 2016 Jun; 145():24-6. PubMed ID: 27012495
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 37. Adult ADHD: Addressing a unique set of challenges.
    Fields SA; Johnson WM; Hassig MB
    J Fam Pract; 2017 Feb; 66(2):68-74. PubMed ID: 28222452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G; Vannucchi G
    Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.
    Biederman J; Wilens T; Mick E; Spencer T; Faraone SV
    Pediatrics; 1999 Aug; 104(2):e20. PubMed ID: 10429138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion.
    Faraone SV; Upadhyaya HP
    J Clin Psychiatry; 2007 Nov; 68(11):e28. PubMed ID: 18052554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.